Showing results (61-70 of 314) with videos related to
Sort By:
Pageof 32
Clinical Kidney Journal|September 9, 2020
Hypoxia response and acute lung and kidney injury: possible implications for therapy of COVID-19Lucia Del Vecchio, Francesco LocatelliCurrent Opinion in Nephrology and Hypertension|May 31, 2018
Will there still be a role for the originator erythropoiesis-simulating agents after the biosimilars and the hypoxia-inducible factor stabilizers approval?Francesco Locatelli, Lucia Del VecchioExpert Opinion on Drug Safety|August 25, 2012
Safety issues related to erythropoiesis-stimulating agents used to treat anemia in patients with chronic kidney diseaseLucia Del Vecchio, Francesco LocatelliExpert Opinion on Pharmacotherapy|June 11, 2014
Efficacy of colestilan in the treatment of hyperphosphataemia in renal disease patientsFrancesco Locatelli, Nada Dimkovic, Goce SpasovskiNature Reviews. Nephrology|November 26, 2009
The growing problem of intradialytic hypertensionFrancesco Locatelli, Andrea Cavalli, Benedetta TucciBlood Purification|July 4, 2015
A Randomized Trial on Health-Related Patient Satisfaction Level with High-Efficiency Online Hemodiafiltration versus High-Flux DialysisAyman Karkar, Mohammed Abdelrahman, Francesco LocatelliIdrugs : the Investigational Drugs Journal|July 16, 2003
Lanthanum carbonate (Shire)Francesco Locatelli, Marco D'Amico, Giuseppe PontorieroExpert Review of Endocrinology & Metabolism|October 9, 2018
Colestilan for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysisFrancesco Locatelli, Nada Dimkovic, Goce SpasovskiNephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 24, 2013
Evaluation of colestilan in chronic kidney disease dialysis patients with hyperphosphataemia and dyslipidaemia: a randomized, placebo-controlled, multiple fixed-dose trialFrancesco Locatelli, Nada Dimkovic, Goce SpasovskiClinical Journal of the American Society of Nephrology : CJASN|April 2, 2011
Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic optionsJohn Cunningham, Francesco Locatelli, Mariano RodriguezPageof 32